Sita Shankar, CCC-SLP in Redmond, WA - Speech-Language Pathologist

Sita Shankar, CCC-SLP is a Speech-language Pathologist based in Redmond, Washington. Sita Shankar is licensed to practice in Washington (license number LL 60431787) and her current practice location is 16343 Ne 50th St, Redmond, Washington. She can be reached at her office (for appointments etc.) via phone at (425) 883-3969.

NPI number for Sita Shankar is 1801211875 and her current mailing address is 16343 Ne 50th St, Redmond, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1801211875.

Contact Information

	Sita Shankar, CCC-SLP
	16343 Ne 50th St, Redmond, WA 98052-5295
	(425) 883-3969
	Not Available

Healthcare Provider's Profile

Full Name	Sita Shankar
Gender	Female
Speciality	Speech-language Pathologist
Location	16343 Ne 50th St, Redmond, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1801211875
Provider Enumeration Date: 02/26/2014
Last Update Date: 02/26/2014

Medical Identifiers

Medical identifiers for Sita Shankar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1801211875	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	LL 60431787 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sita Shankar is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sita Shankar, CCC-SLP 16343 Ne 50th St, Redmond, WA 98052-5295 Ph: (425) 883-3969	Sita Shankar, CCC-SLP 16343 Ne 50th St, Redmond, WA 98052-5295 Ph: (425) 883-3969

News Archive

Daily Beast profiles George W. Bush's post-presidency global health work

The Daily Beast's "U.S. Policy" blog profiles former president George W. Bush's post-presidency work in global health through the Bush Institute, which "houses a variety of programs under the broad headings of global health, education reform, economic growth, and advancing human freedom, areas that advance Bush's interests and reflect his presidency."

Debiopharm signs new license and research agreement with Yale University

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, announced it has signed a new license and research agreement with Yale University (Yale), a premier university with a long tradition of basic and clinical biomedical research, regarding the discovery of MIF inhibitors for treatment of autoimmune and inflammatory diseases.

Two-drug combination may be effective for patients with higher-risk forms of MDS and AML

A phase two study that investigated the potential of the drugs azacitidine (AZA) and lenalidomide (LEN), demonstrated that the two therapies in combination may be an effective frontline treatment regimen for patients with higher-risk forms of myelodysplastic syndrome and acute myeloid leukemia.

Tendyne Feasibility Study: Tendyne successfully implants TMVI system in first patient

Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.

Study finds significant decline of MRSA infections in VA long-term care facilities

Four years after implementing a national initiative to reduce methicillin-resistant Staphylococcus aureus rates in Veterans Affairs long-term care facilities, MRSA infections have declined significantly, according to a study in the January issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

Speech-Language Pathologist in Redmond, WA

Ms. Constance Essinger, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17272 Ne 104th St, Redmond, WA 98052 Phone: 425-936-1800 Fax: 425-936-1810
Peregrine Therapy, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16770 Ne 79th St Ste 105, Redmond, WA 98052 Phone: 425-689-8570 Fax: 425-689-7521
Maivy Ho, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8301 161st Ave Ne Ste 208, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043
Julie M Horace Carlson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8301 161st Ave Ne, #203, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043
Kristen Leucuta, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15325 Redmond Way Apt I2101, Redmond, WA 98052 Phone: 630-946-9026
Sarah Summer Mckim Thomas, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16720 Redmond Way Ste G, Redmond, WA 98052 Phone: 206-486-2906 Fax: 509-821-9219
Colette Moss, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 159th Pl Ne, Redmond, WA 98052 Phone: 425-883-3730

Sita Shankar, CCC-SLP - Speech-Language Pathologist in Redmond, WA